Loading organizations...
Loading organizations...
Key people at Maruho.
Key people at Maruho.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 14, 2025 | Sibel Health | $39.0M Series C Extension | — | Tim Sullivan, Akihiko Ikoma, Jonathan Machado |
| Jun 2, 2022 | Upstream Bio | $200.0M Series A | Maruho, Erez Chimovits, OrbiMed | Access Biotechnology, Altshuler Shaham, Decheng Capital, HBM Healthcare Investments, Omega Funds, Samsara BioCapital, Bernard Davitian, TCGX |
| Jun 1, 2013 | Dermira | $35.0M Series B | — | Canaan Partners, MPM Capital, Pivotal bioVenture Partners, SR One Capital Management, Bay City Capital, Canaan Partners, New Enterprise Associates |